Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension (Q81730686)
Jump to navigation
Jump to search
scientific article published on 31 July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension |
scientific article published on 31 July 2008 |
Statements
Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension (English)
P C M van de Kerkhof
S Segaert
M Lahfa
T A Luger
Z Karolyi
G Leigheb
F M Camacho
D Forsea
C Zang
M P Boussuge
L Paolozzi